Women with FVL thrombophilia in homozygosis or mutant prothrombin in homozygosis, with no previous VTE event and with a family history of thrombosis should perform antithrombotic prophylaxis only in the postpartum period. The gene discussed is F2; the disease is Rare hereditary thrombophilia.